Duravest, Inc.
OTC Bulletin Board : DUVTE

Duravest, Inc.

May 19, 2006 11:12 ET

Duravest Launches New Corporate Web Site Focused on Convergent Medical Technologies

CHICAGO, IL--(CCNMatthews - May 19, 2006) -

Click on www.duravestinc.com for the Industry Information Hub

Duravest, Inc. (OTC BB: DUVTE), (XETRA: DUV), a unique company that strategically acquires and accelerates the development of next generation convergent medical technology firms, today launched a completely redesigned corporate web site dedicated to the advancement of convergent medical technologies within the investment, clinical and academic communities. The site will also feature recent developments and thought-leadership in advancing safety considerations in the development of medical technologies.

The company's new web site, created by Epsilonium Systems, is designed specifically to enhance the knowledge of convergent medical technologies and to be a home for news, information, and important policymaking decisions related to this high growth industry. The new Duravest website will also serve as an important information resource for its investors, subsidiaries, affiliates and other stakeholders.

Duravest's innovative web site can be found at www.duravestinc.com. New content will be added daily.

"We are excited about the role Duravest can take in raising the awareness and accelerating the development of both development-stage and established companies operating in this area," Dr. Ogan Gurel, CEO of Duravest and a noted thought leader in the industry, said Thursday. "The Duravest corporate web site should be a hub for industry professionals, investors, policymakers, scientists, clinicians and the media in the rapidly expanding field of convergent/combination medical technologies."

ARCH Conference Presentation Webcast Available

Dr. Gurel presented at the May 18 ARCH Investment Conference at the Hotel Plaza Athenee in New York City. The purpose of the conference was to introduce high growth companies, like Duravest, to the investment community.

Please visit http://www.investorcalendar.com/CEPage.asp?ID=104912 for the archived web cast of Dr. Gurel's May 18 investor presentation.

The presentation link can also be found at www.duravestinc.com.

About Epsilonium Systems

Epsilonium Systems is an international creative design and e-business applications company developing innovative and sophisticated web solutions for their clients. Headquartered in Phoenix with a location in Kanpur, India, Epsilonium delivers a wide range of design, development, and complete life-cycle management solutions. For more information, please visit www.epsilonium.com.

About Duravest, Inc.

Duravest, Inc. is a publicly traded holding company that initiates and develops strategic investments in next-generation convergent medical technologies. Duravest currently has two subsidiaries: Estracure, Inc. and PST, GmbH (formerly known as Bio-Magnetic Therapy Systems, GmbH). The Duravest strategy encompasses three themes: (1) rapid commercialization of next-generation medical technologies by providing its portfolio of subsidiaries with financial, operational and scientific support, (2) prioritization of safety and (3) development of convergent medical technologies that span the traditional categories of biotechnology, pharmaceuticals, healthcare IT and medical devices.

Safe Harbor Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals or assumptions of future events are not statements of historical fact and may be considered forward-looking statements. They involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated.

Contact Information